ÁöÇ÷/ÀÀ°í ºÐ¼®±â ½ÃÀå : Á¦Ç°º°, °Ë»ç Ç׸ñº°, ±â¼úº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Hemostasis/Coagulation Analyzer Market, By Product, By Test, By Technology, By End User, By Geography
»óǰÄÚµå : 1477209
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2024³â 04¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,274,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,760,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 13,943,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°è ÁöÇ÷/ÀÀ°í ºÐ¼®±â ½ÃÀåÀº 2024³â 43¾ï 6,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2031³â¿¡´Â 64¾ï 7,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 5.8%ÀÇ CAGRÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í¼­ ¹üÀ§ º¸°í¼­ »ó¼¼
±âÁØ ¿¬µµ 2023³â 2024³â ½ÃÀå ±Ô¸ð 43¾ï 6,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£ 2024-2031³â CAGR: 5.80% 2031³â °¡Ä¡ ¿¹Ãø 64¾ï 7,000¸¸ ´Þ·¯
±×¸². ÁöÇ÷/ÀÀ°í ºÐ¼®±â ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â
Hemostasis/Coagulation Analyzer Market-IMG1

ÁöÇ÷/ÀÀ°í ºÐ¼®±â ½ÃÀåÀº Ç÷¾× ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ¿¬°£ ¼ö¼ú °Ç¼ö Áõ°¡·Î ÀÎÇØ Áö³­ ¸î ³â µ¿¾È ²ÙÁØÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ÁöÇ÷ ºÐ¼®±â´Â ÀÀ°í °Ë»ç ¹× ´Ù¾çÇÑ Ç÷¾× ÁúȯÀÇ ¼±º° °Ë»ç¿¡ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ±â±âÀÇ ±â¼ú ¹ßÀüÀ¸·Î ÀÀ°í °Ë»çÀÇ È¿°ú¿Í È¿À²¼ºÀÌ Çâ»óµÇ¾ú½À´Ï´Ù. ¿ÏÀü ÀÚµ¿È­µÈ °íó¸® ÀåºñÀÇ Ã¤ÅÃÀ¸·Î ¸¹Àº ¼öÀÇ °Ëü¸¦ µ¿½Ã¿¡ ó¸®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ±×·¯³ª °í±Þ ºÐ¼® ÀåºñÀÇ ³ôÀº °¡°ÝÀº ¿©ÀüÈ÷ º¸±ÞÀ» Á¦ÇÑÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ:

ÀÀ°í Àå¾Ö ¹ß»ý·üÀÇ Áõ°¡, ÀÀ°í ¹®Á¦¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ÀÇ Áõ°¡, Àü ¼¼°è ¼ö¼ú °Ç¼öÀÇ Áõ°¡°¡ ¼¼°è ÁöÇ÷/ÀÀ°í ºÐ¼®±â ½ÃÀåÀÇ ¼ºÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ºÐ¼® ÀåºñÀÇ ³ôÀº ºñ¿ëÀº ¿©ÀüÈ÷ ½ÃÀåÀÇ ÁÖ¿ä ¾ïÁ¦¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù. ¸¶ÀÌÅ©·Î À¯Ã¼ ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ È޴뼺ÀÌ Çâ»óµÇ°í ¼ÒÇüÈ­µÈ »õ·Î¿î ÇöÀå °Ë»ç Àåºñ°¡ °³¹ßµÉ °¡´É¼ºÀÌ ÀÖ½À´Ï´Ù. ÀΰøÁö´ÉÀÇ ÅëÇÕÀº ÀÚµ¿È­¿Í µ¥ÀÌÅÍ ÇØ¼®À» µ½°í º´¸®ÇÐÀÚ ºÎÁ·À» ÇØ°áÇÏ°í ³³±â¸¦ °³¼±ÇÏ´Â µ¥ µµ¿òÀÌ µÉ °ÍÀÔ´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ÁöÇ÷/ÀÀ°í ºÐ¼®±â ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ÁöÇ÷/ÀÀ°í ºÐ¼®±â ½ÃÀå, Á¦Ç°º°, 2019-2031³â

Á¦6Àå ¼¼°èÀÇ ÁöÇ÷/ÀÀ°í ºÐ¼®±â ½ÃÀå, Å×½ºÆ®º°, 2019-2031³â

Á¦7Àå ¼¼°èÀÇ ÁöÇ÷/ÀÀ°í ºÐ¼®±â ½ÃÀå, ±â¼úº°, 2019-2031³â

Á¦8Àå ¼¼°èÀÇ ÁöÇ÷/ÀÀ°í ºÐ¼®±â ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2031³â

Á¦9Àå ¼¼°èÀÇ ÁöÇ÷/ÀÀ°í ºÐ¼®±â ½ÃÀå, Áö¿ªº°, 2019-2031³â

Á¦10Àå °æÀï »óȲ

Á¦11Àå ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ

Á¦12Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global hemostasis/coagulation analyzer market is estimated to be valued at USD 4.36 Bn in 2024 and is expected to reach USD 6.47 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 5.8% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 4.36 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 To 2031
Forecast Period 2024 to 2031 CAGR: 5.80% 2031 Value Projection: US$ 6.47 Bn
Figure. Hemostasis/Coagulation Analyzer Market Share (%), By Region 2024
Hemostasis/Coagulation Analyzer Market - IMG1

The hemostasis/coagulation analyzer market has been growing at a steady rate over the past few years owing to the rising prevalence of blood disorders and increasing number of surgical procedures performed annually. Hemostasis analyzers help in coagulation testing and screening of various hematological conditions. Technological advancements in these devices have improved efficacy and efficiency of coagulation testing. The adoption of fully automated, high-throughput instruments allows processing of large number of samples simultaneously. However, high costs of advanced analyzers remain a factor limiting widespread adoption.

Market Dynamics:

The global hemostasis/coagulation analyzer market growth is driven by the rising incidence of coagulation disorders, increasing elderly population vulnerable to coagulation issues, and growing number of surgical procedures performed worldwide. However, high costs of analyzers remain a major restraint for the market. Ongoing developments in microfluidics technology provide opportunities for novel point-of-care testing devices with improved portability and miniaturized design. Integration of artificial intelligence aids automation and data interpretation, addressing the shortage of pathologists and improving turnaround times.

Key Features of the Study:

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Hemostasis/Coagulation Analyzer Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Hemostasis/Coagulation Analyzer Market, By Product, 2019 - 2031, (USD Bn)

6. Global Hemostasis/Coagulation Analyzer Market, By Test, 2019 - 2031, (USD Bn)

7. Global Hemostasis/Coagulation Analyzer Market, By Technology, 2019 - 2031, (USD Bn)

8. Global Hemostasis/Coagulation Analyzer Market, By End User, 2019 - 2031, (USD Bn)

9. Global Hemostasis/Coagulation Analyzer Market, By Region, 2019 - 2031, (USD Bn)

10. Competitive Landscape

11. Analyst Recommendations

12. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â